🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 19 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/08/2012 | 10,11 | 10,86 | 10,05 | 10,78 | +6,94% | 8,01% | 1.137.100 |
| 23/08/2012 | 10,25 | 10,25 | 9,99 | 10,08 | +0,00% | 2,54% | 323.700 |
| 22/08/2012 | 10,17 | 10,33 | 9,95 | 10,08 | -0,79% | 3,74% | 476.600 |
| 21/08/2012 | 10,18 | 10,98 | 9,98 | 10,16 | +0,20% | 9,82% | 1.889.200 |
| 20/08/2012 | 9,92 | 10,26 | 9,82 | 10,14 | +0,70% | 4,44% | 512.400 |
| 17/08/2012 | 10,11 | 10,50 | 9,97 | 10,07 | -0,79% | 5,24% | 805.800 |
| 16/08/2012 | 9,27 | 10,50 | 9,05 | 10,15 | +10,33% | 15,64% | 1.662.700 |
| 15/08/2012 | 9,00 | 10,78 | 8,82 | 9,20 | +9,26% | 21,78% | 3.999.800 |
| 14/08/2012 | 8,51 | 8,53 | 8,25 | 8,42 | -0,82% | 3,29% | 278.400 |
| 13/08/2012 | 8,27 | 8,57 | 8,08 | 8,49 | +2,66% | 5,93% | 321.300 |
| 10/08/2012 | 8,22 | 8,40 | 7,92 | 8,27 | +2,73% | 5,84% | 304.500 |
| 09/08/2012 | 7,80 | 8,10 | 7,50 | 8,05 | +3,21% | 7,69% | 1.025.800 |
| 08/08/2012 | 8,45 | 8,49 | 7,76 | 7,80 | -6,14% | 8,64% | 643.200 |
| 07/08/2012 | 8,24 | 8,82 | 8,20 | 8,31 | +0,36% | 7,52% | 440.100 |
| 06/08/2012 | 8,50 | 8,50 | 7,97 | 8,28 | -5,15% | 6,24% | 981.900 |
| 03/08/2012 | 8,92 | 9,01 | 8,65 | 8,73 | -0,23% | 4,04% | 515.100 |
| 02/08/2012 | 9,18 | 9,55 | 8,50 | 8,75 | -4,68% | 11,44% | 969.600 |
| 01/08/2012 | 9,19 | 9,33 | 8,71 | 9,18 | +1,21% | 6,75% | 1.396.900 |
| 31/07/2012 | 9,50 | 9,53 | 8,58 | 9,07 | -4,22% | 10,00% | 1.475.600 |
| 30/07/2012 | 8,82 | 10,25 | 8,61 | 9,47 | +11,94% | 18,59% | 4.887.800 |
| 27/07/2012 | 8,08 | 8,59 | 7,80 | 8,46 | +7,22% | 9,78% | 2.120.700 |
| 26/07/2012 | 7,96 | 8,13 | 7,28 | 7,89 | +2,20% | 10,68% | 1.976.600 |
| 25/07/2012 | 8,29 | 8,47 | 7,53 | 7,72 | -9,39% | 11,34% | 4.445.400 |
| 24/07/2012 | 7,36 | 9,11 | 7,03 | 8,52 | +146,24% | 28,26% | 16.889.000 |
| 23/07/2012 | 3,53 | 3,61 | 3,45 | 3,46 | -4,16% | 4,53% | 71.400 |
| 20/07/2012 | 3,68 | 3,74 | 3,53 | 3,61 | -2,17% | 5,71% | 82.500 |
| 19/07/2012 | 3,83 | 4,02 | 3,63 | 3,69 | +0,54% | 10,18% | 206.700 |
| 18/07/2012 | 3,71 | 3,74 | 3,65 | 3,67 | -3,93% | 2,43% | 104.100 |
| 17/07/2012 | 3,94 | 4,03 | 3,63 | 3,82 | -2,55% | 10,15% | 179.100 |
| 16/07/2012 | 3,73 | 3,92 | 3,73 | 3,92 | +2,35% | 5,09% | 75.000 |